David Soergel
Chief Medical Officer · MADRIGAL PHARMACEUTICALS, INC.
- 2025
- Jun 1, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Soergel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
- Kenneth Bate - $8.03M in MDGL purchases and sales in the last 12 months
- Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
- Mardi Dier - $3.77M in MDGL purchases and sales in the last 12 months
- Carole Huntsman - $1.71M in MDGL purchases and sales in the last 12 months
- Rebecca Taub - $1.63M in MDGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Soergel?
David Soergel is a corporate insider, tracked as Chief Medical Officer of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David Soergel last file a Form 4?
The most recent primary Form 4 on record is dated 1 June 2026, one of 4 filings going back to 2025.
Has David Soergel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($952K) across all tracked filings.
